2014 Opportunities in the Global Sexually-Transmitted Diseases (STD) Diagnostic Testing Market

2014 Opportunities in the Global Sexually-Transmitted Diseases (STD) Diagnostic Testing Market

Category : Diagnostic and Biotech
Published On : December  2013

------------ Or -------------

Complete report $9,600.  DataPack (test volumes, sales forecasts, supplier shares) $6,200.

This new 350-page report from Venture Planning Group contains 90 tables and provides analysis of the global sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. 

The report presents detailed analysis of the STD market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan.  Current scientific views on epidemiology and etiology are presented for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis.  The report provides test volume and sales forecasts by country and market segment, including:


     - Hospitals
     - Commercial/Private Labs
     - Physician Offices
     - Public Health Labs      

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of STD diagnostic products, by test and country.  Also, the report:

     -  Examines market applications of Molecular Diagnostics,  

        Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;

     -  Reviews features and operating characteristics of major analyzers used 

        for STD testing;

     -  Profiles key suppliers and potential market entrants developing innovative

        technologies and products; and


     -  Analyzes emerging opportunities, alternative market penetration strategies, 
         market entry barriers/risks, and strategic planning issues.


The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U.S., five major European countries and Japan.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as Venture Planning Group’s proprietary data files was conducted.

Contains 350 pages and 90 tables

Can't read the image ? refresh here.

Enquiry Before Buy
Can´t read the image ? refresh here.